1. SAT0142 Immunogenicity Assessment of PF-06438179, A Potential Biosimilar to Infliximab, In Healthy Volunteers. (9th June 2015) Authors: Udata, C.; Yin, D.; Cai, C.-H.; Hua, S.Y.; Salts, S.; Rehman, M.I.; AL-Sabbagh, A.; McClellan, J.; Meng, X. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 702 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. SAT0172 Establishing Margins to Demonstrate Equivalence in Efficacy for Biosimilar Clinical Trials in Rheumatoid Arthritis Patients: A Meta-Analysis Approach. (9th June 2015) Authors: Hua, S.Y.; Barker, K.B.; Qu, P.; Rehman, M.I.; Schaum, R.; Visvalingam, S.; McClellan, J.E.; Salts, S.; AL-Sabbagh, A. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 716 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗